5'-OMe-Vinyl Phosphonate, 2'-OMe-U CE-Phosphoramidite
Methoxy-protected phosphoramidite for incorporation of a 5′-(E)-Vinylphosphonate (VP) moiety into an oligonucleotide.
Methoxy-protected phosphoramidite for incorporation of a 5′-(E)-Vinylphosphonate (VP) moiety into an oligonucleotide.
POM-protected phosphoramidite for incorporation of a 5′-(E)-Vinylphosphonate (VP) moiety into an oligonucleotide.
CPG column for incorporation of cholesterol at 3' end of an oligonucleotide, with a dR spacer.
CPG column used to incorporate a lipophilic palmitoyl-modifier at the 3' end of an oligonucleotide.
Phosphoramidite for N-Acetylgalactosamine (GalNAc) incorporation in an oligonucleotide.
CPG column for incorporation of GalNAc at 3' end of an oligonucleotide, with a dR spacer
CPG for incorporation of GalNAc at 3' end of an oligonucleotide, with a dR spacer
Phosphoramidite for incorporation of cholesterol internally or at 5' end of an oligonucleotide, with a triethylene glycol spacer.
Cholesteryl-modified linker synthon.
CPG for incorporation of cholesterol at 3' end of an oligonucleotide, with a triethylene glycol spacer.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |